AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
Eldorado buys Caesars Entertainment to create the largest owner & operator of casinos in the U.S. Dan Kline analyzes the hidden value in the deal and why he believes it will pay off down the line. Plus, we discuss the current state of the burger industry and the “disappointing” weekend at the box office for Toy Story 4. Thanks Netsuite. Get the FREE guide, “7 Key Strategies to Grow your Profits” at www.NetSuite.com/Fool.
Slack makes its debut as a public company. Will the cloud-based collaboration platform make it rain for investors? Analysts Andy Cross and Ron Gross tackle that question and discuss interest rates, Olive Garden, and the future of Google. Thanks to NetSuite. Download their FREE guide, “Seven Key Strategies to Grow your Profits,” today at www.NetSuite.com/Fool.
Adobe’s 2nd-quarter revenue rose 25% sending shares higher. Winnebago’s 3rd-quarter report showed improving margins. MFAM Funds portfolio manager Bill Barker analyzes those stories as well as the on-again-off-again deal between Mattel and MGA Entertainment. Plus, we look forward to this weekend’s opening of “Toy Story 4.” Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.
Facebook unveils its new digital currency. Sotheby’s goes private. And a new bill on Capitol Hill aims to level the playing field for investors. Bill Mann analyzes those stories, as well as the latest food business in Germany and a surprising liquor story from Canada. Thanks to NetSuite. Download their FREE guide, “Seven Key Strategies to Grow your Profits” today at www.NetSuite.com/Fool.
Pfizer buys Array Biopharma for $11.4 billion, sending shares of Array up 57%. Ron Gross analyzes the acquisition spree among big pharmaceutical companies. Target has a massive outage over the weekend, but we still have a few more questions about why. Plus, we dip into the Fool Mailbag and discuss the latest news from Papa John’s. Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.
Lululemon athletica and RH both rise on strong 1st-quarter reports, but MFAM Funds portfolio manager Bill Barker is more bullish on one than the other. Plus, Suntrust and BB&T unveil the name of their recently-merged $66 billion bank and it’s……Truist??? We share our reactions, as well as the business case against the new name. (Tangents include competitive yoga, why the Stanley Cup is the best trophy in North American sports, and how the classic movie “This Is Spinal Tap” relates to the 6th-largest bank in the U.S.)
Dave & Buster’s misses quarterly earnings by one penny and shares drop 22%. Seth Jayson analyzes why a new multi-year low isn’t enough to get him interested in this stock. Plus, we discuss Tesla’s annual meeting, TheStreet.com leaving the public markets, and a preview of Lululemon athletica’s upcoming earnings report. Get $50 off your first job post at www.LinkedIn.com/Fool.
Casey’s General Stores hits a new all-time high after blowout 4th-quarter earnings. Bill Mann analyzes how Casey’s is quietly a threat to McDonald’s. Plus, we discuss Foxconn’s potential move out of China, Wells Fargo’s challenge to find a new CEO, and highlights from FoolFest 2019.
United Technologies and Raytheon combine forces to form the second largest aerospace and defense company in the U.S. Salesforce.com buys Tableau Software. Video conferencing technology company Zoom continues its rise. And Canadian cannabis producer Tilray surges on good news. Get $50 off your first job post at www.LinkedIn.com/Fool.
Get more great information on becoming a better investor -- free and straight to your inbox!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions.